Feldschuh to head business development and strategic initiatives Daxor Corp (AMEX: DXR) announced today that it has appointed Michael Feldschuh as Executive Vice President, to head business development and strategic initiatives for Daxor Corporation as part of the firm’s effort to build its medical device business. “We have exciting strategic goals for our medical device […]
Daxor Corporation, (NYSE MKT: DXR) announced its funding of a major study today for treating heart failure. The principal investigator for the study is Wayne Miller, M.D., PhD. Dr. Miller and his associates previously conducted a study on heart failure patients which was recently published in the Journal of the American College of Cardiology-Heart Failure. […]
The BVA-100 is the first FDA Approved machine to accurately measure blood volume in as little as 30 minutes. Review our product literature to learn more.